Dealhoy becomes CBO at Deciphera

Deciphera Pharmaceuticals Inc. (NASDAQ:DCPH) hired Kelley Dealhoy as SVP and CBO. Dealhoy joins the oncology company from Novartis AG (SIX:NOVN; NYSE:NVS), where she was most recently VP and global head of oncology business development and licensing. Prior to that, she was at Interface Biologics Inc. and Deloitte LLP. 

Glycobiology and protein degradation company GlycoEra AG hired Tanmoy Ganguly as CSO. Ganguly was VP of leading pharmacology, research analytics and bioinformatics at Evelo Biosciences Inc. (NASDAQ:EVLO) and worked at Momenta Pharmaceuticals Inc. for 11 years. GlycoEra hired Ganesh Kaundinya as president and CEO in May. ...